Interventional Oncology Market Growth Fueled by Image-Guided Procedures

The global interventional oncology market size was estimated at USD 2.90 billion in 2025 and is projected to reach USD 5.61 billion by 2033, growing at a CAGR of 8.59% from 2026 to 2033. This growth can be attributed to the increasing prevalence of cancer, increasing technological advancements in minimally invasive procedures, growing geriatric population, rising focus on early cancer detection, and increasing public and private investments in the field of interventional oncology. Healthcare providers are increasingly adopting image-guided and minimally invasive treatment approaches to improve patient outcomes, reduce recovery times, and minimize procedure-related complications. The growing burden of cancer worldwide continues to drive demand for advanced treatment options that offer precision and effectiveness.

Interventional oncology is a specialized field that utilizes minimally invasive, image-guided procedures for the diagnosis and treatment of cancer. These procedures are often used as alternatives or complements to traditional treatments such as surgery, chemotherapy, and radiation therapy. The increasing availability of advanced imaging technologies and the growing acceptance of minimally invasive techniques are supporting the expansion of the market across hospitals, cancer treatment centers, and specialty clinics. Continuous advancements in treatment technologies are further contributing to the adoption of interventional oncology procedures.

Download a free sample copy of the Interventional Oncology market report to understand detailed coverage and inclusions in the final report

Key Market Trends & Insights

1. North America’s interventional oncology devices market held the largest share of 41.80% of the global market in 2025. The region benefits from advanced healthcare infrastructure, high healthcare expenditure, strong research and development activities, and widespread adoption of innovative cancer treatment technologies. The growing prevalence of cancer and increasing awareness regarding minimally invasive treatment options continue to support market growth. In addition, the presence of leading medical device manufacturers and specialized oncology centers strengthens the region's market position.
2. The U.S. interventional oncology market is anticipated to witness lucrative growth over the forecast period. Increasing investments in cancer research, rising demand for advanced treatment procedures, and growing adoption of image-guided interventions are contributing to market expansion. Healthcare providers across the country are increasingly utilizing minimally invasive therapies to improve treatment efficiency and patient outcomes. The continued focus on innovation and cancer care advancements is expected to support sustained market growth.
3. By technique, the ablation therapies segment dominated the market in 2025 with the largest revenue share. Ablation therapies are widely used to destroy cancerous tissues through minimally invasive procedures while minimizing damage to surrounding healthy tissues. These therapies offer several clinical advantages, including shorter recovery periods, reduced hospital stays, and improved patient comfort. The increasing use of ablation technologies for the treatment of various cancer types has contributed significantly to the segment's leading market position.
4. By procedures, the vascular intervention segment held a leading market share of 38.1% in 2025. Vascular interventions play an important role in the treatment of cancer by enabling targeted delivery of therapeutic agents directly to tumors. These procedures help improve treatment precision while reducing systemic exposure to medications. The growing adoption of catheter-based and image-guided vascular procedures in oncology care continues to support the dominance of this segment within the market.
5. By application, the liver cancer segment accounted for the largest revenue share of 27.8% in 2025. Interventional oncology procedures are widely utilized in the treatment of liver cancer due to their ability to provide targeted and minimally invasive therapeutic options. The increasing incidence of liver cancer globally, combined with growing awareness regarding advanced treatment approaches, is contributing to strong demand within this segment. The effectiveness of interventional oncology techniques in managing liver tumors continues to support the segment's leadership position in the market.

Looking for more specific insights? Customize this report to suite your business needs

Key Companies & Market Share Insights

Key players operating in the interventional oncology market are undertaking various initiatives to strengthen their market presence and increase the reach of their products and services. Strategies such as expansion activities and partnerships are playing a key role in propelling market growth.

Key Interventional Oncology Companies:

1. Medtronic plc
2. Boston Scientific Corporation
3. Johnson & Johnson (Ethicon)
4. Teleflex Incorporated
5. Cook Medical
6. AngioDynamics Inc.
7. Stryker Corporation
8. Profound Medical
9. Terumo Corporation
10. Siemens Healthineers

Explore Grand View Horizon to see global and regional level statistics related to the Interventional Oncology Market

Grand View Research offers

1. Focused market intelligence reports on specific geographies or high-growth segments.
2. Extended forecast timelines for long-term planning.
3. Competitor Benchmarking and Supply Chain Analysis
4. Inclusion of regulatory and policy assessments.
5. Inclusion of custom data models, KPIs, or applications unique to your business
6. Specific high-impact Data Decks and Tables to support effective decision making
7. And much more…

Looking for a report customized to your requirements? Explore our Custom Research Offering